Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152372 · ClinicalTrials.gov registry record · Phase 1
Experimental Study to Validate the Modified Glucose Disposal Test
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01152372 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 36 participants.
The verdict
NCT01152372, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus
Interventions
- PROCEDURE Insulin, glucose and staple isotopes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152372
The ClinicalTrials.gov registry entry for NCT01152372 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin, glucose and staple isotopes is the first listed.
NCT01152372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01152372 about?
NCT01152372 is a clinical study titled "Experimental Study to Validate the Modified Glucose Disposal Test". Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus
What is the current status of trial NCT01152372?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2010-06. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01152372?
The interventions under investigation include: Insulin, glucose and staple isotopes (PROCEDURE).
Who is sponsoring clinical trial NCT01152372?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.